Salvadoran Doctor Sets Sights on Changing Pediatric Oncology in Her Country

SOG_1264_13SMALL

By Dr. Soad Fuentes Alabi Soad Fuentes Alabi, MD, visited Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as part of the Global Health Initiative. She shares her experience with Insight readers. In El Salvador, where I come from, in a population of more than 5 million, there are almost 1.1 million children ages 1-14. For all of those children, there is only one pediatric hospital. As a doctor who specializes in pediatric oncology, I was thrilled when I got the chance to come to America. Through the St. Baldrick’s International Scholar Award, I had the opportunity to come to the U.S. …

Continue reading

Boston Mayor Marty Walsh ‘Proud to be a Cancer Survivor’

SOG_2120_14

Boston Mayor Marty Walsh recently gave the keynote address at Dana-Farber’s Living Proof: Celebrating Survivorship event. He shared his experience as a child being treated for Burkitt’s lymphoma at Dana-Farber and Boston Children’s Hospital. Below are some excerpts from his speech:  I was diagnosed with cancer at age 7. I went through treatment for almost four years. At 7-years old, I didn’t really know what was going on and how serious it was – and it was pretty serious. For many years I missed a lot of school. I missed most of my second and third grades. When I finally went into remission, …

Continue reading

Young Adult Artist and Athlete Determined to Win the Fight Against Cancer

SOG_0009_14SMALL

The below interview with patient Fernando Morales was featured in the 2014 Spring/Summer issue of Dana-Farber’s Paths of Progress, now available as a free app for iPad.  My cancer diagnosis came right smack in the middle of high school. I was diagnosed with Ewing sarcoma in March 2011, my sophomore year. I had to give up sports and stop going to school while I did 14 rounds of chemotherapy and 31 rounds of radiation. I promised myself I would fight through it. And I didn’t let myself get down when I lost my ability to play soccer. I relapsed in October 2012 …

Continue reading

As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond

SOG_1740_14SMALL

  Jessica Tierney never thought she’d experience a harder moment than learning she had cancer at age 15 – until her 7-year-old daughter, Emma, was diagnosed with acute lymphocytic leukemia (ALL) last October. Emma is undergoing treatment at Boston Children’s Hospital and Dana-Farber’s Jimmy Fund Clinic, just as Jessica did in 1991. “Emma already knew I had once been really sick, so I told her, ‘Look at me. I was treated a long time ago, and the medicine is even better now,” Jessica Tierney recalls of hearing her daughter’s diagnosis. Jessica is a survivor of acute myeloid leukemia, or AML, …

Continue reading

At Dana-Farber, Every Beam Tells a Story of Growth — and Survival

When Dana-Farber Cancer Institute was founded as the Children’s Cancer Research Foundation in 1947, childhood cancer was almost universally fatal. In the years since, as Dana-Farber’s researchers and clinicians have helped dramatically raise survival rates for many pediatric and adult cancers, its campus in Boston’s Longwood Medical Area has grown as well. Patients are the motivation for each new building that rises at Dana-Farber, and in the case of two recent structures, are even immortalized within – thanks to special bonds formed during their construction. After years of working first in a tiny basement laboratory and then in an apartment …

Continue reading

New Research Shows Promise for Pediatric Brain Tumor Treatment

SOG_2960_14-2

Every year, about 4,700 children in the United States are diagnosed with brain cancer –­ making it the most common solid tumor in children. It is also one of the most difficult cancers to treat. Brain tumors are the leading cause of cancer-related deaths in children under age 10 and the second leading cause of cancer deaths in people under 20. Although survival rates for children with some types of brain tumors have risen over the past 30 years, current research aims to increase those rates dramatically in the years ahead. Scientists are focusing on the basic genetic and genomic …

Continue reading

Star-Studded Support for Dana-Farber

4.28.14 Star StuddedSmall

A group of influential theater owners known as the Variety Club of New England were touring Boston Children’s Hospital in 1947 when they happened upon a tiny basement laboratory. Here, Sidney Farber, MD, was conducting research that would lead to the first remissions in pediatric leukemia. The men were so impressed by Farber they decided to help his efforts. Calling on their Hollywood friends, the group held a fundraising drive that enabled Farber to establish the Children’s Cancer Research Foundation – now known as Dana-Farber Cancer Institute. Ever since, celebrities have been supporters of Dana-Farber and the Jimmy Fund. In 1948, …

Continue reading

Young Patient Inspires with Fashion and Beauty Blog

4.16.14 Young Patient InspiresSmall

When 15-year-old Karina Moreira sat down with Brazilian model Gisele Bundchen in December 2013, the two traded beauty tips, talked fashion, and took turns applying makeup. They spoke in their native Portuguese and laughed with family and friends. The experience, Moreira says, one that she will remember for the rest of her life. But the two talked about more than just eye shadow and clothes; they also talked about life and Moreira’s battle with bone cancer. Bundchen, who surprised Moreira at home, offered some advice for the young girl: “When life gives you lemons, make lemonade.” “My life may be …

Continue reading

To Share or Not to Share? That is the Question

4.9.14 To Share or NotSmall

One of the most difficult aspects of having cancer is deciding who to tell and when. For young adults who may be attending college, maintaining an active social life, or starting a family, these questions are especially critical. Karen Fasciano, PsyD, and her colleagues in the Young Adult Program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), addressed these questions and others at the 11th annual Young Adult Cancer Conference last month. Bruce MacDonald, MSW, LICSW, who leads the young adult cancer support group at DF/BWCC, spoke with patients about sharing their diagnoses with three critical groups: Family and Friends While …

Continue reading

When is an Antipsychotic Not an Antipsychotic? When it’s an Antileukemic

By Tom Ulrich One of the hot trends in drug discovery could be called drug re-discovery: finding new uses for drugs that have already received FDA approval for a different indication. It’s an approach that allows researchers and clinicians to rapidly test potential treatments for rare or difficult-to-treat conditions. Because the drug’s safety profile is already known, much of the preclinical and early clinical work that goes into developing a drug can be bypassed.